ASSESSMENT OF RILMENIDINE EFFICIENCY IN PATIENTS WITH ARTERIAL HYPERTENSION WITH DETERIORATION OF DAILY PROFILE OF BLOOD PRESSURE
<p><strong>Aim.</strong> To estimate an efficiency and tolerability of rilmenidine in hypertensive patients with different types of blood pressure (BP) daily profile - dipper and non-dipper.</p><p><strong>Methods.</strong> 23 patients with essential hyperten...
Saved in:
Main Authors: | , |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2015-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_b95d843468be453685536e3cf671b51c | ||
042 | |a dc | ||
100 | 1 | 0 | |a P. P. Tikhonov |e author |
700 | 1 | 0 | |a L. A. Sokolova |e author |
245 | 0 | 0 | |a ASSESSMENT OF RILMENIDINE EFFICIENCY IN PATIENTS WITH ARTERIAL HYPERTENSION WITH DETERIORATION OF DAILY PROFILE OF BLOOD PRESSURE |
260 | |b Столичная издательская компания, |c 2015-12-01T00:00:00Z. | ||
500 | |a 1819-6446 | ||
500 | |a 2225-3653 | ||
500 | |a 10.1234/1819-6446-2005-2-14-19 | ||
520 | |a <p><strong>Aim.</strong> To estimate an efficiency and tolerability of rilmenidine in hypertensive patients with different types of blood pressure (BP) daily profile - dipper and non-dipper.</p><p><strong>Methods.</strong> 23 patients with essential hypertension (EH), I-II stages, were included into the study. They were treated with rilmeneidine 1 mg daily during one month. Ambulatory BP monitoring (ABPM) and office BP measurements were made before and after the treatment. Based on ABPM results all patients were divided into two groups: with adequate decrease of BP at nighttime (dipper, D), and with insufficient decrease of BP at nighttime (non-dipper, ND).</p><p><strong>Results.</strong> One month rilmenidine monotherapy resulted in BP normalization in 52% of patients. Decrease in 24-hour BP, daytime and nighttime BP, burden with BP and BP variability during daytime was observed in both groups. A distinction in rilmenidine influence on BP daily index was revealed: initially normal BP daily index didn't change in D group, while initially decreased BP daily index increased in ND group. Rilmenidine reduced the speed of morning BP rise in patients of ND group.</p><p><strong>Conclusion.</strong> Results of the study testify efficiency and satisfactory tolerability of monotherapy with rilmenidine 1 mg daily in patients with EH of I-II stages. For patients with insufficient decrease in BP during nighttime rilmenidine provides normalization of BP daily profile intensifying BP night decrease and reducing the speed of morning BP rise.</p> | ||
546 | |a EN | ||
546 | |a RU | ||
690 | |a артериальная гипертензия | ||
690 | |a суточный профиль АД | ||
690 | |a рилменидин | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
690 | |a Diseases of the circulatory (Cardiovascular) system | ||
690 | |a RC666-701 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Рациональная фармакотерапия в кардиологии, Vol 1, Iss 2, Pp 14-19 (2015) | |
787 | 0 | |n http://www.rpcardio.ru/jour/article/view/348 | |
787 | 0 | |n https://doaj.org/toc/1819-6446 | |
787 | 0 | |n https://doaj.org/toc/2225-3653 | |
856 | 4 | 1 | |u https://doaj.org/article/b95d843468be453685536e3cf671b51c |z Connect to this object online. |